Company Overview and News
Chicago, IL – April 10, 2018 - Stocks in this week’s article Weight Watchers International, Inc. (WTW - Free Report) , Match Group, Inc. (MTCH - Free Report) , Dynegy Inc. and HFF, Inc. (HF - Free Report) .
The first-quarter earnings season began Monday. With the stock market struggling lately, there seem to be a lot of bulls hanging their hopes on earnings strength to help pull the market out of correction territory.
It’s a different market than it was at the end of January. Volatility has returned, even if it remains modest relative to historical levels. Big names like Procter & Gamble Co (NYSE:PG) and Walmart Inc (NYSE:WMT), among others, have seen precipitous share price declines after record highs.
When value or growth investing fails to fetch sustained profits, one should explore another time-tested winning strategy that simply bets on the frontrunner stocks. Translated, one of the most successful strategies today is to get in on momentum stocks at the right time.
Rent-A-Center, Inc. (RCII - Free Report) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $7.65 –$9.22 in the past one-month time frame, witnessed a sharp increase on Friday.
Weight Watchers International, Inc. (NYSE:WTW) has enjoyed a great twelve months, and Weight Watchers stock has more than quadrupled in that time. But growth catalysts have become murkier even as the company pursues new ventures. With the stock price increases it looks like most of the growth is already priced in.
Problems have plagued Blue Apron Holdings Inc (NYSE:APRN) ever since it launched its IPO. Low margins and the entrance of large competitors into the market have left Blue Apron stock with no obvious avenues for profitability.
The first quarter was an eventful one for U.S. equity markets. The quarter — and the year — started off well. A rally that had started in November 2016 U.S. continued through the end of January. The S&P 500 was at an all-time high — and the tech-heavy Nasdaq Composite was performing even better.
After a 14-month bull run, the stock market has seen a return in volatility of late — and a few big sell-offs. It’s clearly a more nervous market, and that means investors have to be more careful in choosing what stocks to buy.
After a blockbuster start to 2018, Wall Street has been caught in a vicious circle of trading over the past two months as volatility and uncertainty have taken the center stage. While a combination of factors like solid earnings, upbeat economic data and new tax legislation have fueled the rally, inflation fears, protectionist and anti-trade Trump policies, Washington turmoil and faster-than-expected rates hike continue to weigh on stock returns.
It’s a different market than it was just two months ago. Volatility has returned, even if it remains modest relative to historical levels. Big names like Procter & Gamble Co (NYSE:PG) and Walmart Inc (NYSE:WMT), among others, have seen precipitous share price declines just in the past few weeks.
Global consumer tax services provider, H&R Block, Inc. (HRB - Free Report) announced that it has entered into a partnership with LendingTree, Inc. in order to help clients better understand their financial situation. The deal will also provide clients easy access to their credit score, LendingTree Academy and others. LendingTree operates solely in the United States and is considered to be the nation's leading online loan marketplace.
Chicago, IL – March 13, 2018 - Stocks in this week’s article include: Sony Corporation (SNE - Free Report) , Atlas Air Worldwide Holdings, Inc. (AAWW - Free Report) , Mammoth Energy Services, Inc. (TUSK - Free Report) , Paycom Software, Inc. (PAYC - Free Report) and Weight Watchers International, Inc. (WTW - Free Report) .
The best possible way to evaluate a company’s ability to meet all operating costs and expenses and still provide excellent returns is profitability analysis. If a company has strong profitability but weak fundamentals, it might weigh on its stock performance. However, several studies highlighted that a company with high profitability normally offers considerable gains to investors.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET